Invest Michigan
  • Home
  • About
  • Team
  • Portfolio
  • Press
  • Contact

Revolutionizing Precision Medicine

August 12, 2020

This is an article about portfolio company, Genomenon.

An accomplished businessman, a strategic thinker and an excellent leader, Mike Klein has been responsible for raising over $50 million in private equity and venture capital financing over the years. He has drawn on a unique blend of vision, tactical thinking, communication and, execution skills in the last 25 years of his career. Mike’s technical and financial backgrounds have helped him bolster businesses and meet their objectives while driving revenue growth. Excerpts from an interview with Mike Klein, CEO, Genomenon:

View source version on tech-ceos.com: https://www.tech-ceos.com/genomenon/

Newer
All
Older

Contact

Invest Michigan
235 E. Main Street, Suite 105B
Northville, MI 48167
Email info@investmichigan.org
© 2025 Invest Michigan Powered by Jottful